Monash IVF GroupASX:MVF 78 Dividend Yield % is 1.69% as of Jun. 25, 2026, which is 68% below its 10-year median of 5.27. GuruFocus rates ASX:MVF with a GF Score™ of 78/100 and a GF Value™ of A$1.39 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 65 Medical Diagnostics & Research companies, Monash IVF Group ranks worse than 55.38% on this metric.
As of today (2026-06-25), the Trailing Annual Dividend Yield of Monash IVF Group is 1.69%.
Warning Sign:
Monash IVF Group Ltd stock Dividend Yield % is close to 10-year low.
The historical rank and industry rank for Monash IVF Group's Dividend Yield % or its related term are showing as below:
ASX:MVF'
s Dividend Yield % Range Over the Past 10 Years
Min: 1.69 Med: 5.27 Max: 13.42
Current: 1.69
During the past 12 years, the highest Dividend Yield of Monash IVF Group was 13.42%. The lowest was 1.69%. And the median was 5.27%.
ASX:MVF's Dividend Yield % is ranked worse than 55.38% of 65
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.02
vs ASX:MVF: 1.69
During the past 12 months, Monash IVF Group's average Dividends Per Share Growth Rate was -48.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 5.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 8.20% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -2.60% per year.
During the past 12 years, the highest 3-Year average Dividends Per Share Growth Rate of Monash IVF Group was 35.10% per year. The lowest was -34.30% per year. And the median was -4.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Monash IVF Group (ASX:MVF) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Monash IVF Group's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:MVF vs TMO, DHR, IDXX: Dividend Yield % Comparison
For the Diagnostics & Research subindustry, Monash IVF Group's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monash IVF Group Dividend Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Monash IVF Group's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Monash IVF Group's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Monash IVF Group Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
AUD 0.012000
2026-03-04
2026-03-05
2026-04-10
Cash Dividend
semi-annually
AUD:AUD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Monash IVF Group's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monash IVF Group (ASX:MVF) has a Dividend Yield % of 1.69% as of Jun. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Monash IVF Group and its competitors. This is 68% below median its historical median of 5.27. Over the past decade, Monash IVF Group's Dividend Yield % has ranged from 1.69 to 13.42. According to the industry distribution chart, Monash IVF Group ranks #36 out of 65 companies in the Medical Diagnostics & Research industry, placing it in the top 55.4%.
Is Monash IVF Group's Dividend Yield % too high?
Monash IVF Group's current Dividend Yield % of 1.69% is 68% below median its 10-year median of 5.27. Over the past 10 years, this metric has ranged from a low of 1.69 to a high of 13.42. The Medical Diagnostics & Research industry median Dividend Yield % is 2.02. Monash IVF Group's value of 1.69% is 16.3% below this industry median. Based on the distribution chart, Monash IVF Group ranks #36 out of 65 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Monash IVF Group has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Monash IVF Group's Dividend Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Monash IVF Group ranks #36 out of 65 companies for Dividend Yield %. This places Monash IVF Group in the lower half of its industry. The industry median Dividend Yield % is 2.02. Monash IVF Group's value of 1.69% is 16.3% below this benchmark. Historically, Monash IVF Group's own Dividend Yield % has ranged from 1.69 to 13.42 over the past decade. While the company's 10-year median is 5.27 vs. the industry median of 2.02, Monash IVF Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Diagnostics & Research company?
The median Dividend Yield % among Medical Diagnostics & Research companies is 2.02, based on 65 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Monash IVF Group's current Dividend Yield % of 1.69% is 16.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Monash IVF Group and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Yield % is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Monash IVF Group's current Dividend Yield % is 1.69%, which is 68% below median its own 10-year median of 5.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monash IVF Group stock overvalued right now?
Based on GuruFocus' analysis, Monash IVF Group (ASX:MVF) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.39, compared to a current price of A$0.71 — trading 48.9% below its estimated fair value. The current Dividend Yield % is 1.69%, which is 68% below median its 10-year median of 5.27 and 16.3% below the Medical Diagnostics & Research industry median of 2.02. Monash IVF Group's overall GF Score™ is 78/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Monash IVF Group (ASX:MVF), the current Dividend Yield % is 1.69% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monash IVF Group (ASX:MVF) Overvalued in 2026?
Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued.
The current stock price of A$0.71 is trading 48.9% below its estimated GF Value™ of A$1.39.
GuruFocus considers Monash IVF Group to be Possible Value Trap.
Key valuation signals for ASX:MVF:
Dividend Yield %: 1.69% (68% below median its 10-year median of 5.27)
GF Value™: A$1.39 vs. price of A$0.71 (48.9% below fair value)
Industry Position: 16.3% below the Medical Diagnostics & Research median (#36 of 65)
No single metric tells the full story. See the ASX:MVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
78GF Score
Get the complete analysis for ASX:MVF
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MVF has been successfully added to your 
